Astrazeneca upholds vaccine safety amid health concerns
Image Credit: newsbytes
AstraZeneca has reaffirmed its dedication to patient safety amid reports of rare side effects from the AstraZeneca-Oxford COVID-19 vaccine. The company emphasized that "patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines," according to a spokesperson. The company's declaration came days after it admitted that its COVID-19 vaccines "Covishield" and "Vaxzevria" may cause Thrombosis Thrombocytopenia Syndrome (TTS) in rare cases.